Pub Date : 2024-03-01DOI: 10.1016/j.hlpt.2023.100809
Ana Rita Sousa Sequeira , Marta Estrela , Kelsey DeWit
Background
Countries have adopted different COVID-19 policies to contain the transmission of the disease and to prepare for vaccination rollout. Countries’ political context, vaccine policy history, and health systems’ responses impacted COVID-19 health outcomes.
Objective
This study focused on synthesizing and examining COVID-19 non-pharmaceutical interventions in Brazil and Portugal, understanding the enablers and barriers to COVID-19 vaccination access and distribution, and health and non-health outcomes across three time-points: before vaccination, during mass vaccination, and after the declaration of endemicity.
Methods
Extensive qualitative document analysis of secondary sources published in Portuguese and English over the past three years, and examination of primary publicly available epidemiological data since the beginning of the pandemic.
Results
In the first year of the pandemic, the COVID-19 government response between the two countries was dissimilar; effective coordination, trust in the government response and political alignment in Portugal contrasted the political denial of the pandemic, lack of coordination between the various levels of government, at the same time the Brazilian population engaged in protective behaviours and distrusted the government. The COVID-19 vaccination had a good response from the public, associated with a primary care level network of distribution, low vaccine hesitancy, and strong childhood immunization programs before the pandemic in both countries. Vaccine manufacturing in Brazil and the strong support from the European Union to Portugal on vaccine acquisition have also aided these countries in achieving high COVID-19 vaccination coverage.
Conclusion
Future policies to promote a well-functioning and resilient health system should consider medical and nursing workforce sustainability, equity in all policies, building public trust, strengthening health system governance, and improving preparedness and surveillance.
{"title":"COVID-19 Government policies in Portugal and Brazil: A three-year retrospective analysis","authors":"Ana Rita Sousa Sequeira , Marta Estrela , Kelsey DeWit","doi":"10.1016/j.hlpt.2023.100809","DOIUrl":"10.1016/j.hlpt.2023.100809","url":null,"abstract":"<div><h3>Background</h3><p>Countries have adopted different COVID-19 policies to contain the transmission of the disease and to prepare for vaccination rollout. Countries’ political context, vaccine policy history, and health systems’ responses impacted COVID-19 health outcomes.</p></div><div><h3>Objective</h3><p>This study focused on synthesizing and examining COVID-19 non-pharmaceutical interventions in Brazil and Portugal, understanding the enablers and barriers to COVID-19 vaccination access and distribution, and health and non-health outcomes across three time-points: before vaccination, during mass vaccination, and after the declaration of endemicity.</p></div><div><h3>Methods</h3><p>Extensive qualitative document analysis of secondary sources published in Portuguese and English over the past three years, and examination of primary publicly available epidemiological data since the beginning of the pandemic.</p></div><div><h3>Results</h3><p>In the first year of the pandemic, the COVID-19 government response between the two countries was dissimilar; effective coordination, trust in the government response and political alignment in Portugal contrasted the political denial of the pandemic, lack of coordination between the various levels of government, at the same time the Brazilian population engaged in protective behaviours and distrusted the government. The COVID-19 vaccination had a good response from the public, associated with a primary care level network of distribution, low vaccine hesitancy, and strong childhood immunization programs before the pandemic in both countries. Vaccine manufacturing in Brazil and the strong support from the European Union to Portugal on vaccine acquisition have also aided these countries in achieving high COVID-19 vaccination coverage.</p></div><div><h3>Conclusion</h3><p>Future policies to promote a well-functioning and resilient health system should consider medical and nursing workforce sustainability, equity in all policies, building public trust, strengthening health system governance, and improving preparedness and surveillance.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100809"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000850/pdfft?md5=bfb85ba953c7fd3c1d8b33778fddcd7c&pid=1-s2.0-S2211883723000850-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135427895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.hlpt.2023.100779
Angela Wong , Claudia Zoller , Ayman Fouda , Francesco Paolucci
Objective
This study aims to examine the interplay between high policy stringency, vaccination rates and epidemiological outcomes to develop insights on COVID-19 policy transition in Singapore
Methods
The CPTI (Categorising Policy & Technology Interventions) framework was used to classify reported interventions from January 2021 to October 2022. To analyse the impact of vaccine measures, an additional category was created. The highest monthly proportion of de-escalated measures was used as a basis to define the periods that mark the policy transition in Singapore i.e. Phase 2 and 3. Proportions of significantly escalated measures were calculated and analysed against full and booster vaccination rates, alongside epidemiological indicators – monthly total number of infections and deaths, and monthly average active hospitalisation and ICU cases.
Results
Implementation of highly stringent policies were observed to have reduced in intensity as vaccination rates picked up from Phase 2 to 3. Containment measures were the most frequently and consistently adopted beside vaccine policies. Epidemiological indicators appeared to be generally lower in Phase 3 than Phase 2. Specifically, despite reduced intensity of stringent polices, hospitalisation and ICU cases were observed to remain relatively low when vaccination rates were correspondingly higher in Phase 3 compared to Phase 2.
Conclusion
The descriptive analysis of COVID-19 policy shift in Singapore based on selected indicators preliminarily suggested its successful transition from the pandemic to endemic phase in its response strategies. A policy transition plan should consider the significance of vaccination rates in an exit strategy that protects the population against worse health outcomes.
{"title":"Are we past the COVID-19 Pandemic? Insights from Singapore","authors":"Angela Wong , Claudia Zoller , Ayman Fouda , Francesco Paolucci","doi":"10.1016/j.hlpt.2023.100779","DOIUrl":"10.1016/j.hlpt.2023.100779","url":null,"abstract":"<div><h3>Objective</h3><p>This study aims to examine the interplay between high policy stringency, vaccination rates and epidemiological outcomes to develop insights on COVID-19 policy transition in Singapore</p></div><div><h3>Methods</h3><p>The CPTI (Categorising Policy & Technology Interventions) framework was used to classify reported interventions from January 2021 to October 2022. To analyse the impact of vaccine measures, an additional category was created. The highest monthly proportion of de-escalated measures was used as a basis to define the periods that mark the policy transition in Singapore i.e. Phase 2 and 3. Proportions of significantly escalated measures were calculated and analysed against full and booster vaccination rates, alongside epidemiological indicators – monthly total number of infections and deaths, and monthly average active hospitalisation and ICU cases.</p></div><div><h3>Results</h3><p>Implementation of highly stringent policies were observed to have reduced in intensity as vaccination rates picked up from Phase 2 to 3. Containment measures were the most frequently and consistently adopted beside vaccine policies. Epidemiological indicators appeared to be generally lower in Phase 3 than Phase 2. Specifically, despite reduced intensity of stringent polices, hospitalisation and ICU cases were observed to remain relatively low when vaccination rates were correspondingly higher in Phase 3 compared to Phase 2.</p></div><div><h3>Conclusion</h3><p>The descriptive analysis of COVID-19 policy shift in Singapore based on selected indicators preliminarily suggested its successful transition from the pandemic to endemic phase in its response strategies. A policy transition plan should consider the significance of vaccination rates in an exit strategy that protects the population against worse health outcomes.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100779"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000552/pdfft?md5=89c380f51b12f1cd14ee67d4a79ffb64&pid=1-s2.0-S2211883723000552-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43887302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.hlpt.2023.100792
Asmita P. Khatiwada , Mesfin G. Genie , Aregawi G. Gebremariam , Tim C. Lai , Nabin Poudel , Surachat Ngorsuraches
Objective
Little is known about the relative effectiveness of COVID-19 vaccination and its interaction with non-pharmaceutical interventions (NPIs) in reducing infections, deaths, COVID-19 reproduction rate, and job losses. This study examined the relative effectiveness of vaccination and NPIs on COVID-19 infection, deaths, reproduction rate, and unemployment rate in the US.
Methods
Retrospective US data at the national level were obtained from the Oxford COVID-19 Government Response Tracker (OxCGRT dataset). Unemployment rate data were obtained from the US Bureau of Labor Statistics. Time-trend analyses of the policy variables and epidemiological outcomes were performed. A regression discontinuity in time was used to investigate the effects of policy variables on health outcomes and unemployment rate.
Results
Based on time-trend analyses, the number of people vaccinated increased starting in March 2021, while the stringency index had steadily declined since early January 2021. A decrease in new COVID-19 cases and deaths was observed during this period. However, despite higher vaccination coverage, new COVID-19 cases and deaths peaked in late 2021 and early 2022. We found that the interaction between treatment effects (vaccinations) and stringency measures was negatively associated with total COVID-19 cases and deaths, implying that some restrictions might be required to reduce rising infections during vaccination campaigns. We also found a negative association between vaccinations and the unemployment rate.
Conclusion
The study findings suggested that vaccinations alone were insufficient to reduce virus spread and deaths, and that some NPIs might be required during the vaccination campaigns.
{"title":"Vaccination and non-pharmaceutical interventions during COVID-19: Impact on health and non-health outcomes in the US","authors":"Asmita P. Khatiwada , Mesfin G. Genie , Aregawi G. Gebremariam , Tim C. Lai , Nabin Poudel , Surachat Ngorsuraches","doi":"10.1016/j.hlpt.2023.100792","DOIUrl":"10.1016/j.hlpt.2023.100792","url":null,"abstract":"<div><h3>Objective</h3><p>Little is known about the relative effectiveness of COVID-19 vaccination and its interaction with non-pharmaceutical interventions (NPIs) in reducing infections, deaths, COVID-19 reproduction rate, and job losses. This study examined the relative effectiveness of vaccination and NPIs on COVID-19 infection, deaths, reproduction rate, and unemployment rate in the US.</p></div><div><h3>Methods</h3><p>Retrospective US data at the national level were obtained from the Oxford COVID-19 Government Response Tracker (OxCGRT dataset). Unemployment rate data were obtained from the US Bureau of Labor Statistics. Time-trend analyses of the policy variables and epidemiological outcomes were performed. A regression discontinuity in time was used to investigate the effects of policy variables on health outcomes and unemployment rate.</p></div><div><h3>Results</h3><p>Based on time-trend analyses, the number of people vaccinated increased starting in March 2021, while the stringency index had steadily declined since early January 2021. A decrease in new COVID-19 cases and deaths was observed during this period. However, despite higher vaccination coverage, new COVID-19 cases and deaths peaked in late 2021 and early 2022. We found that the interaction between treatment effects (vaccinations) and stringency measures was negatively associated with total COVID-19 cases and deaths, implying that some restrictions might be required to reduce rising infections during vaccination campaigns. We also found a negative association between vaccinations and the unemployment rate.</p></div><div><h3>Conclusion</h3><p>The study findings suggested that vaccinations alone were insufficient to reduce virus spread and deaths, and that some NPIs might be required during the vaccination campaigns.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100792"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000680/pdfft?md5=692402b6a561e3282d83f2f039f7c768&pid=1-s2.0-S2211883723000680-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49564409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.hlpt.2024.100854
Marcello Antonini , Ayman Fouda , Madeleine Hinwood , Adrian Melia , Francesco Paolucci
{"title":"The interplay between global health policy and vaccination strategies in the shift towards COVID-19 endemicity","authors":"Marcello Antonini , Ayman Fouda , Madeleine Hinwood , Adrian Melia , Francesco Paolucci","doi":"10.1016/j.hlpt.2024.100854","DOIUrl":"10.1016/j.hlpt.2024.100854","url":null,"abstract":"","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100854"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883724000170/pdfft?md5=4fcbe34afc1cf0ab64a3f366cd71fc01&pid=1-s2.0-S2211883724000170-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139883744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.hlpt.2023.100783
Anouk van Amerongen , Claudia Zoller , Ayman Fouda
Introduction
The COVID-19 pandemic has presented global challenges in the health, economy, society, and political sector for the past three years. For the Netherlands, the dynamic nature of the pandemic can be divided into three phases. The initial phase exclusively relied on non-pharmaceutical interventions (NPIs). The second phase was characterized by the introduction of vaccines alongside the continuation of stringent NPIs. Finally, the third phase marks the post-vaccine and booster stage, characterized by minimal or absent NPIs. This paper examines the interplay between the mitigation policies, the vaccination rollout, health outcomes, and economic indicators in the Netherlands in these three phases.
Methods
This analysis used national real-time data on COVID-19-related health outcomes, health service utilization, vaccination rollout, and economic indicators. Our descriptive analysis applied the “Categorising Policy & Technology Interventions (CPTI)” framework.
Results
The number of daily deaths, hospital admission and ICU admission experienced the highest peak in the first phase, while the number of daily cases first spiked in the third phase. The containment measures reached a very significant level twice, resulting in a full lockdown twice. In the first two phases, the peak in stringency of the CPTI containment category was parallel with the peaks in health outcomes. Conversely, in the third phase, the containment measures were scaled down prior to the peak in daily cases.
Conclusions
Our findings suggest that the Dutch three-phased COVID-19 mitigation strategy managed to fulfil its aim and protect vulnerable individuals, prevent healthcare institutions from overload, and move from the pandemic to the endemic phase.
{"title":"COVID-19 in the Netherlands: A three-phase analysis","authors":"Anouk van Amerongen , Claudia Zoller , Ayman Fouda","doi":"10.1016/j.hlpt.2023.100783","DOIUrl":"10.1016/j.hlpt.2023.100783","url":null,"abstract":"<div><h3>Introduction</h3><p>The COVID-19 pandemic has presented global challenges in the health, economy, society, and political sector for the past three years. For the Netherlands, the dynamic nature of the pandemic can be divided into three phases. The initial phase exclusively relied on non-pharmaceutical interventions (NPIs). The second phase was characterized by the introduction of vaccines alongside the continuation of stringent NPIs. Finally, the third phase marks the post-vaccine and booster stage, characterized by minimal or absent NPIs. This paper examines the interplay between the mitigation policies, the vaccination rollout, health outcomes, and economic indicators in the Netherlands in these three phases.</p></div><div><h3>Methods</h3><p>This analysis used national real-time data on COVID-19-related health outcomes, health service utilization, vaccination rollout, and economic indicators. Our descriptive analysis applied the “Categorising Policy & Technology Interventions (CPTI)” framework.</p></div><div><h3>Results</h3><p>The number of daily deaths, hospital admission and ICU admission experienced the highest peak in the first phase, while the number of daily cases first spiked in the third phase. The containment measures reached a very significant level twice, resulting in a full lockdown twice. In the first two phases, the peak in stringency of the CPTI containment category was parallel with the peaks in health outcomes. Conversely, in the third phase, the containment measures were scaled down prior to the peak in daily cases.</p></div><div><h3>Conclusions</h3><p>Our findings suggest that the Dutch three-phased COVID-19 mitigation strategy managed to fulfil its aim and protect vulnerable individuals, prevent healthcare institutions from overload, and move from the pandemic to the endemic phase.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100783"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221188372300059X/pdfft?md5=5bda2b559d9531a5cbdb9d7cbaab7ac1&pid=1-s2.0-S221188372300059X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47607647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.hlpt.2023.100813
Julio A. Pertuze , José Pablo Montégu , Cecilia González , Rafael Araos , Paula Daza
Objectives
This study evaluates the effects of COVID-19 lockdowns, differentiated by their stringency, on the sales of Chilean businesses across various size categories and industries throughout 2020 and 2021. It also explores the role of the vaccination campaign and the implementation of the Mobility Pass in mitigating the negative economic effects of stringent containment measures.
Methods
The study uses administrative data from the Chilean Internal Revenue Service (SII), examining sales across different business sizes and industries, from March 2020 to December 2021. Through an econometric analysis, we estimate the effects of lockdowns on business sales during two distinct periods: initial reliance on dynamic non-pharmaceutical interventions (NPIs) pre-vaccine, and a subsequent stage characterized by high vaccine uptake and reduced NPI stringency.
Results
Lockdowns significantly reduced sales across all business sizes and most industries during the first period, with microenterprises and certain service sectors experiencing the highest decline. The national vaccination campaign and the introduction of the Mobility Pass in the second period appears to have mitigated the negative effects of lockdowns, primarily benefiting micro and small firms.
Conclusions
The study highlights the trade-offs between health and economic outcomes during the pandemic, stressing the importance to alleviate mobility restrictions post-vaccine rollout to ease the economic strain on businesses. The findings call for targeted support measures for MSMEs and vulnerable industries affected by NPIs.
{"title":"Navigating economic turmoil: Chilean businesses during COVID-19 lockdowns and vaccine rollouts","authors":"Julio A. Pertuze , José Pablo Montégu , Cecilia González , Rafael Araos , Paula Daza","doi":"10.1016/j.hlpt.2023.100813","DOIUrl":"10.1016/j.hlpt.2023.100813","url":null,"abstract":"<div><h3>Objectives</h3><p>This study evaluates the effects of COVID-19 lockdowns, differentiated by their stringency, on the sales of Chilean businesses across various size categories and industries throughout 2020 and 2021. It also explores the role of the vaccination campaign and the implementation of the Mobility Pass in mitigating the negative economic effects of stringent containment measures.</p></div><div><h3>Methods</h3><p>The study uses administrative data from the Chilean Internal Revenue Service (SII), examining sales across different business sizes and industries, from March 2020 to December 2021. Through an econometric analysis, we estimate the effects of lockdowns on business sales during two distinct periods: initial reliance on dynamic non-pharmaceutical interventions (NPIs) pre-vaccine, and a subsequent stage characterized by high vaccine uptake and reduced NPI stringency.</p></div><div><h3>Results</h3><p>Lockdowns significantly reduced sales across all business sizes and most industries during the first period, with microenterprises and certain service sectors experiencing the highest decline. The national vaccination campaign and the introduction of the Mobility Pass in the second period appears to have mitigated the negative effects of lockdowns, primarily benefiting micro and small firms.</p></div><div><h3>Conclusions</h3><p>The study highlights the trade-offs between health and economic outcomes during the pandemic, stressing the importance to alleviate mobility restrictions post-vaccine rollout to ease the economic strain on businesses. The findings call for targeted support measures for MSMEs and vulnerable industries affected by NPIs.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100813"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000898/pdfft?md5=f9c5f0284ed129531c147f26758177de&pid=1-s2.0-S2211883723000898-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134995166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-18DOI: 10.1016/j.hlpt.2023.100821
Mana Azarm , Rebecca Meehan , Craig Kuziemsky
Abstract
摘要。
{"title":"Corrigendum to ‘Towards a universal patient-centric health record sharing platform’ [Health Policy and Technology 12 (2023) 100819]","authors":"Mana Azarm , Rebecca Meehan , Craig Kuziemsky","doi":"10.1016/j.hlpt.2023.100821","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100821","url":null,"abstract":"<div><p>Abstract</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100821"},"PeriodicalIF":6.0,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000977/pdfft?md5=0b347d243a5a26d272b0236c8b84f9e6&pid=1-s2.0-S2211883723000977-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138453984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-18DOI: 10.1016/j.hlpt.2023.100825
Daniel L. Young , Rebecca Engels , Elizabeth Colantuoni , Lisa Aronson Friedman , Erik H. Hoyer
None
没有一个
{"title":"Corrigendum to ‘Machine learning prediction of hospital patient need for post-acute care using an admission mobility measure is robust across patient diagnoses’ [Health Policy and Technology 12 (2023) 100,754]","authors":"Daniel L. Young , Rebecca Engels , Elizabeth Colantuoni , Lisa Aronson Friedman , Erik H. Hoyer","doi":"10.1016/j.hlpt.2023.100825","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100825","url":null,"abstract":"<div><p>None</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100825"},"PeriodicalIF":6.0,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723001016/pdfft?md5=127e2af5e8991d39e0edc980c50fad49&pid=1-s2.0-S2211883723001016-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138453983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-12DOI: 10.1016/j.hlpt.2023.100824
Dacre R.T. Knight , Christopher A. Aakre , Christopher V. Anstine , Bala Munipalli , Parisa Biazar , Ghada Mitri , Jose Raul Valery , Tara Brigham , Shehzad K. Niazi , Adam I. Perlman , John D. Halamka , Abd Moain Abu Dabrh
<div><h3>Objectives</h3><p>The application of artificial intelligence (AI) and machine learning (ML) to scheduling in medical practices has considerable implications for most specialties. However, the landscape of AI and ML use in scheduling optimization is unclear. We aimed to systematically summarize up-to-date evidence about application of AI and ML models for scheduling optimization in clinical settings.</p></div><div><h3>Methods</h3><p><span>We systematically searched multiple databases from inception through August 2020 to identify studies that described real-world application of AI and ML in health care scheduling and reported outcomes. Eligible studies included those conducted in any health care setting using ML or </span>predictive modeling through AI to optimize patient scheduling processes in real-time, real-world settings. Outcomes of interest included assessing impact on stakeholders (i.e., providers, patients, health systems), including impact on workload, burden, burnout, cost, utilization, patient and provider satisfaction, waste reduction, and quality. Data were extracted and reviewed in duplicates, independently and blindly by two reviewers. The results were synthesized and summarized using a metanarrative approach.</p></div><div><h3>Results</h3><p>The initial search strategy yielded 3,415 citations, of which 11 eligible studies were included. Outcome measures for studies on missed appointments covered patient double-booking volume, missed appointments, service use, and missed appointment risk. Resource allocation outcomes assessed wait time, disease-type matching performance, schedule efficiency revenue, and new patient volume wait time. Other outcomes included visit requests, examination length prediction, and surgical case time.</p></div><div><h3>Conclusions</h3><p>Available evidence shows heterogeneity in the stages of AI and ML development as they apply to patient scheduling. AI and ML applications can be used to decrease the burden on provider time, increase patient satisfaction, and ultimately provide more patient-directed health care and efficiency for medical practices. These findings help identify additional opportunities in which AI platforms can be developed to optimize patient scheduling.</p></div><div><h3>Public Interest Summary</h3><p><span>Artificial Intelligence (AI) and machine learning (ML) can help many aspects of health care. Patient scheduling has significant implications for the cost benefits of improved technology. The longstanding use of technology in medicine serves as a strong foundation for future AI applications. Here, we present an up-to-date review of the current use of AI and ML for schedule optimization in the health care clinic setting. Current evidence shows a wide variety of stages in the development, function, and application of AI and ML </span>in patient scheduling. Given the current gaps of knowledge, future studies should address feasibility, effectiveness, generalizability, and risk of A
{"title":"Artificial intelligence for patient scheduling in the real-world health care setting: A metanarrative review","authors":"Dacre R.T. Knight , Christopher A. Aakre , Christopher V. Anstine , Bala Munipalli , Parisa Biazar , Ghada Mitri , Jose Raul Valery , Tara Brigham , Shehzad K. Niazi , Adam I. Perlman , John D. Halamka , Abd Moain Abu Dabrh","doi":"10.1016/j.hlpt.2023.100824","DOIUrl":"10.1016/j.hlpt.2023.100824","url":null,"abstract":"<div><h3>Objectives</h3><p>The application of artificial intelligence (AI) and machine learning (ML) to scheduling in medical practices has considerable implications for most specialties. However, the landscape of AI and ML use in scheduling optimization is unclear. We aimed to systematically summarize up-to-date evidence about application of AI and ML models for scheduling optimization in clinical settings.</p></div><div><h3>Methods</h3><p><span>We systematically searched multiple databases from inception through August 2020 to identify studies that described real-world application of AI and ML in health care scheduling and reported outcomes. Eligible studies included those conducted in any health care setting using ML or </span>predictive modeling through AI to optimize patient scheduling processes in real-time, real-world settings. Outcomes of interest included assessing impact on stakeholders (i.e., providers, patients, health systems), including impact on workload, burden, burnout, cost, utilization, patient and provider satisfaction, waste reduction, and quality. Data were extracted and reviewed in duplicates, independently and blindly by two reviewers. The results were synthesized and summarized using a metanarrative approach.</p></div><div><h3>Results</h3><p>The initial search strategy yielded 3,415 citations, of which 11 eligible studies were included. Outcome measures for studies on missed appointments covered patient double-booking volume, missed appointments, service use, and missed appointment risk. Resource allocation outcomes assessed wait time, disease-type matching performance, schedule efficiency revenue, and new patient volume wait time. Other outcomes included visit requests, examination length prediction, and surgical case time.</p></div><div><h3>Conclusions</h3><p>Available evidence shows heterogeneity in the stages of AI and ML development as they apply to patient scheduling. AI and ML applications can be used to decrease the burden on provider time, increase patient satisfaction, and ultimately provide more patient-directed health care and efficiency for medical practices. These findings help identify additional opportunities in which AI platforms can be developed to optimize patient scheduling.</p></div><div><h3>Public Interest Summary</h3><p><span>Artificial Intelligence (AI) and machine learning (ML) can help many aspects of health care. Patient scheduling has significant implications for the cost benefits of improved technology. The longstanding use of technology in medicine serves as a strong foundation for future AI applications. Here, we present an up-to-date review of the current use of AI and ML for schedule optimization in the health care clinic setting. Current evidence shows a wide variety of stages in the development, function, and application of AI and ML </span>in patient scheduling. Given the current gaps of knowledge, future studies should address feasibility, effectiveness, generalizability, and risk of A","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100824"},"PeriodicalIF":6.0,"publicationDate":"2023-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135713776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-10DOI: 10.1016/j.hlpt.2023.100823
Zhongzhou Xiao , Wei Zhai , Xinwei Peng , Yun Zhong , Shuqing Luo , Ruiyao Chen , Lu Lu , Yijue Zhang , Jie Xu
<div><h3><strong>Objectives</strong></h3><p>The significance of safeguarding patient privacy at a population level within public medical institutions remains insufficiently acknowledged despite the potential to enhance the protection awareness of physicians and of hospital management in clinical practice. We herein devised a survey to investigate the current state of patient privacy breaches in China and to ascertain its underlying rationales.</p></div><div><h3><strong>Methods</strong></h3><p><span>We conducted a comprehensive nationwide survey of 928 physicians in seven geographic regions of China through convenience and snowball sampling, enrolled physicians defined in the Chinese Health Statistics Yearbook, and measured the incidence of medical data breaches. Physicians’ perceptions and behaviors with respect to patient privacy protection and their attitudes toward hospital management were accessed through descriptive statistics. Multiple </span>logistic regression analysis was also conducted with different adjustments of covariates for each model.</p></div><div><h3><strong>Results</strong></h3><p>Of the 937 respondents, 928 physicians were eligible and validated for the analysis. We estimated that 52.2 % (95 %CI, 48.9–55.4) of the physicians reported that they had disclosed their patients’ privacy. Master's (OR, 0.63 [95 %CI, 0.43–0.92]) and Ph.D. (OR, 0.59 [95 %CI, 0.35–1.00]) educational levels, scores on the understanding of patient privacy protection (OR, 0.89 [95 %CI, 0.80–0.99]), the presence of colleagues who had experienced data disclosure (OR, 7.00 [95 %CI, 5.02–9.77]), full-time department supervision (OR, 1.60 [95 %CI, 1.02–2.53]) and corresponding regulations (OR, 0.56 [95 %CI, 0.33–0.97]) for patient privacy protection in the hospital, restricted external equipment for computers (OR, 1.76 [95 %CI, 1.10–2.83]), and access to medical records (OR, 0.62 [95 %CI, 0.41–0.94]) were all associated with privacy breaches by physicians.</p></div><div><h3><strong>Conclusions</strong></h3><p>In general, patient privacy research and awareness of patient privacy protection are relatively deficient in China, with a remarkably high occurrence of disclosure. We posit that the identification of the factors underlying our results will provide evidence for appropriate hospital management, and that these factors may then be generalizable to other clinical settings.</p></div><div><h3><strong>Public interest summary</strong></h3><p>Patient privacy breaches seem to be rarely mentioned and addressed regardless of the country, potentially due to its high sensitivity, while this is significant in clinical practice. In this study, we meant to find out the answers to the questions, “What is the situation of privacy disclosure in China public medical institutions?”, “Why does it happen?”, and “Is patient privacy protected enough? If not, how can we do better?”. Through conducting a survey among physicians, their answers were collected for further analysis. Our
{"title":"A national survey of physicians regarding protection of patient privacy in China","authors":"Zhongzhou Xiao , Wei Zhai , Xinwei Peng , Yun Zhong , Shuqing Luo , Ruiyao Chen , Lu Lu , Yijue Zhang , Jie Xu","doi":"10.1016/j.hlpt.2023.100823","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100823","url":null,"abstract":"<div><h3><strong>Objectives</strong></h3><p>The significance of safeguarding patient privacy at a population level within public medical institutions remains insufficiently acknowledged despite the potential to enhance the protection awareness of physicians and of hospital management in clinical practice. We herein devised a survey to investigate the current state of patient privacy breaches in China and to ascertain its underlying rationales.</p></div><div><h3><strong>Methods</strong></h3><p><span>We conducted a comprehensive nationwide survey of 928 physicians in seven geographic regions of China through convenience and snowball sampling, enrolled physicians defined in the Chinese Health Statistics Yearbook, and measured the incidence of medical data breaches. Physicians’ perceptions and behaviors with respect to patient privacy protection and their attitudes toward hospital management were accessed through descriptive statistics. Multiple </span>logistic regression analysis was also conducted with different adjustments of covariates for each model.</p></div><div><h3><strong>Results</strong></h3><p>Of the 937 respondents, 928 physicians were eligible and validated for the analysis. We estimated that 52.2 % (95 %CI, 48.9–55.4) of the physicians reported that they had disclosed their patients’ privacy. Master's (OR, 0.63 [95 %CI, 0.43–0.92]) and Ph.D. (OR, 0.59 [95 %CI, 0.35–1.00]) educational levels, scores on the understanding of patient privacy protection (OR, 0.89 [95 %CI, 0.80–0.99]), the presence of colleagues who had experienced data disclosure (OR, 7.00 [95 %CI, 5.02–9.77]), full-time department supervision (OR, 1.60 [95 %CI, 1.02–2.53]) and corresponding regulations (OR, 0.56 [95 %CI, 0.33–0.97]) for patient privacy protection in the hospital, restricted external equipment for computers (OR, 1.76 [95 %CI, 1.10–2.83]), and access to medical records (OR, 0.62 [95 %CI, 0.41–0.94]) were all associated with privacy breaches by physicians.</p></div><div><h3><strong>Conclusions</strong></h3><p>In general, patient privacy research and awareness of patient privacy protection are relatively deficient in China, with a remarkably high occurrence of disclosure. We posit that the identification of the factors underlying our results will provide evidence for appropriate hospital management, and that these factors may then be generalizable to other clinical settings.</p></div><div><h3><strong>Public interest summary</strong></h3><p>Patient privacy breaches seem to be rarely mentioned and addressed regardless of the country, potentially due to its high sensitivity, while this is significant in clinical practice. In this study, we meant to find out the answers to the questions, “What is the situation of privacy disclosure in China public medical institutions?”, “Why does it happen?”, and “Is patient privacy protected enough? If not, how can we do better?”. Through conducting a survey among physicians, their answers were collected for further analysis. Our","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100823"},"PeriodicalIF":6.0,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134656463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}